121 related articles for article (PubMed ID: 23222168)
1. Thrombelastographic characterization of coagulation/fibrinolysis in horses: role of carboxyheme and metheme states.
Olver CS; Nielsen VG
Blood Coagul Fibrinolysis; 2013 Apr; 24(3):273-8. PubMed ID: 23222168
[TBL] [Abstract][Full Text] [Related]
2. Carbon monoxide and nitric oxide modulate α₂-antiplasmin and plasmin activity: role of heme.
Arkebauer MR; Kanaparthy SS; Malayaman SN; Vosseller K; Nielsen VG
Blood Coagul Fibrinolysis; 2011 Dec; 22(8):712-9. PubMed ID: 22024794
[TBL] [Abstract][Full Text] [Related]
3. Tobacco smoke-induced hypercoagulation in human plasma: role of carbon monoxide.
Nielsen VG; Hafner DT; Steinbrenner EB
Blood Coagul Fibrinolysis; 2013 Jun; 24(4):405-10. PubMed ID: 23429254
[TBL] [Abstract][Full Text] [Related]
4. Redox-based thrombelastographic method to detect carboxyhemefibrinogen-mediated hypercoagulability.
Nielsen VG; Arkebauer MR; Vosseller K
Blood Coagul Fibrinolysis; 2011 Dec; 22(8):657-61. PubMed ID: 21822126
[TBL] [Abstract][Full Text] [Related]
5. Carbon monoxide releasing molecule-2 enhances coagulation and diminishes fibrinolytic vulnerability in subjects exposed to warfarin.
Nielsen VG; Khan ES; Kirklin JK; George JF
Thromb Res; 2010 Jul; 126(1):68-73. PubMed ID: 20406708
[TBL] [Abstract][Full Text] [Related]
6. Carbon monoxide releasing molecule-2 enhances coagulation and attenuates fibrinolysis by two mechanisms: insights gained with colloid dilution.
Cohen JB; Persaud JM; Malayaman SN; Nielsen VG
Blood Coagul Fibrinolysis; 2011 Jan; 22(1):60-6. PubMed ID: 21157300
[TBL] [Abstract][Full Text] [Related]
7. Carbon monoxide releasing molecule-2 enhances α2-antiplasmin activity.
Malayaman SN; Cohen JB; Machovec KA; Bernhardt BE; Arkebauer MR; Nielsen VG
Blood Coagul Fibrinolysis; 2011 Jun; 22(4):345-8. PubMed ID: 21330914
[TBL] [Abstract][Full Text] [Related]
8. Carbon monoxide-releasing molecule-2 decreases fibrinolysis in human plasma.
Nielsen VG; Kirklin JK; George JF
Blood Coagul Fibrinolysis; 2009 Sep; 20(6):448-55. PubMed ID: 19581800
[TBL] [Abstract][Full Text] [Related]
9. Carbon monoxide releasing molecule-2 attenuates the anticoagulant and amplifies the hypofibrinolytic effects of hypothermia in human plasma in vitro.
Nielsen VG; George SJ
Blood Coagul Fibrinolysis; 2011 Jan; 22(1):67-72. PubMed ID: 21157299
[TBL] [Abstract][Full Text] [Related]
10. Freezing does not decrease carbon monoxide-mediated hypercoagulation and hypofibrinolysis in human plasma.
Nielsen VG; Hafner DT
Blood Coagul Fibrinolysis; 2012 Dec; 23(8):784-6. PubMed ID: 22964769
[TBL] [Abstract][Full Text] [Related]
11. The antifibrinolytic effects of carbon monoxide-releasing molecule-2 are fibrin and alpha2-antiplasmin dependent.
Nielsen VG
Blood Coagul Fibrinolysis; 2010 Sep; 21(6):584-7. PubMed ID: 20683324
[TBL] [Abstract][Full Text] [Related]
12. Carbon monoxide releasing molecule-2 improves protamine-mediated hypocoagulation/hyperfibrinolysis in human plasma in vitro.
Nielsen VG; Malayaman SN; Cohen JB; Persaud JM
J Surg Res; 2012 Apr; 173(2):232-9. PubMed ID: 20950825
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the effects of CORM-2, CORM-3 and CORM-A1 on coagulation in human plasma.
Nielsen VG; Garza JI
Blood Coagul Fibrinolysis; 2014 Dec; 25(8):801-5. PubMed ID: 25058038
[TBL] [Abstract][Full Text] [Related]
14. Carbon monoxide releasing molecule-2 increases the velocity of thrombus growth and strength in human plasma.
Nielsen VG; Kirklin JK; George JF
Blood Coagul Fibrinolysis; 2009 Jul; 20(5):377-80. PubMed ID: 19417630
[TBL] [Abstract][Full Text] [Related]
15. Carbon monoxide releasing molecule-2 enhances coagulation and diminishes fibrinolytic vulnerability in plasma exposed to heparin or argatroban.
Nielsen VG; Khan ES; Kirklin JK; George JF
Anesth Analg; 2010 Dec; 111(6):1347-52. PubMed ID: 21048101
[TBL] [Abstract][Full Text] [Related]
16. Fibrinogen is a heme-associated, carbon monoxide sensing molecule: a preliminary report.
Nielsen VG; Cohen JB; Malayaman SN; Nowak M; Vosseller K
Blood Coagul Fibrinolysis; 2011 Jul; 22(5):443-7. PubMed ID: 21451399
[TBL] [Abstract][Full Text] [Related]
17. Hemodialysis patients have plasmatic hypercoagulability and decreased fibrinolytic vulnerability: role of carbon monoxide.
Matika RW; Nielsen VG; Steinbrenner EB; Sussman AN; Madhrira M
ASAIO J; 2014; 60(6):716-21. PubMed ID: 25232771
[TBL] [Abstract][Full Text] [Related]
18. Differential heme-mediated modulation of Deinagkistrodon, Dispholidus, Protobothrops and Pseudonaja hemotoxic venom activity in human plasma.
Nielsen VG; Frank N
Biometals; 2018 Dec; 31(6):951-959. PubMed ID: 30132273
[TBL] [Abstract][Full Text] [Related]
19. Carbon monoxide inhibits hemotoxic activity of Elapidae venoms: potential role of heme.
Nielsen VG; Frank N; Matika RW
Biometals; 2018 Feb; 31(1):51-59. PubMed ID: 29170850
[TBL] [Abstract][Full Text] [Related]
20. Antithrombotic properties of water-soluble carbon monoxide-releasing molecules.
Kramkowski K; Leszczynska A; Mogielnicki A; Chlopicki S; Fedorowicz A; Grochal E; Mann B; Brzoska T; Urano T; Motterlini R; Buczko W
Arterioscler Thromb Vasc Biol; 2012 Sep; 32(9):2149-57. PubMed ID: 22772756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]